Evidence map›Paper›PMID 36646809›Full record

ArticleNature reviews. Drug discovery2023

Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing.

Francesco Marchetti, Renato Cardoso, Connie L Chen, George R Douglas, Joanne Elloway, Patricia A Escobar, Tod Harper, Robert H Heflich, Darren Kidd, Anthony M Lynch and 10 more

Abstract readNews
PubMed Publisher
In one paragraph

Article in Nature reviews. Drug discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Guidelines for the assessment and control of mutagenic impurities in pharmaceuticals.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Benchmark Response (BMR) Values for In Vivo Mutagenicity Endpoints.Environmental and molecular mutagenesis · 2025
    Article
  16. Review
  17. Effect of sequencing platforms on the sensitivity of chemical mutation detection using Hawk-Seq™.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Francesco Marchetti
Renato Cardoso
Connie L Chen
George R Douglas
Joanne Elloway
Patricia A Escobar
Tod Harper
Robert H Heflich
Darren Kidd
Anthony M Lynch
Meagan B Myers
Barbara L Parsons
Jesse J Salk
Raja S Settivari
Stephanie L Smith-Roe
Kristine L Witt
Carole Yauk
Robert R Young
Shaofei Zhang
Sheroy Minocherhomji

Funding

Pathology Services Supporting the Division Translational ToxicologyZICES103376 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CESTA, MARK · 2022 to 2025
$23.9M
ZIA CARCI Carcinogenicity Health Effects innovation Research ProgramZIAES103383 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI PANDIRI, ARUN KUMAR · 2022 to 2025
$13.0M
Development of a Genotoxicity Assay using Duplex SequencingR44ES030642 · NIEHS · TWINSTRAND BIOSCIENCES, INC. · PI SALK, JESSE J · 2019 to 2021
$1.7M
NIEHS NIH HHS R44 ES030642
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA DamageHigh-Throughput Nucleotide SequencingCarcinogenicity TestsHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.